May 10 |
Evaxion receives Nasdaq notification over minimum stockholders’ equity requirement
|
May 10 |
Evaxion Receives Nasdaq Notification
|
May 7 |
Sidoti Events, LLC's Virtual May Micro-Cap Conference
|
Apr 17 |
Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01
|
Apr 3 |
Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data
|
Apr 3 |
Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript
|
Apr 2 |
Evaxion Biotech A/S (EVAX) Q4 2023 Earnings Call Transcript
|
Apr 2 |
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
|
Mar 31 |
Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration
|
Mar 27 |
Evaxion Biotech ADS GAAP EPS of -$0.81
|